Parliamentary panel tells Centre to promote cheaper, domestically produced COVID-19 medicines
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment.
New Delhi: A Parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and cap prices of expensive medicines pushed by pharma companies, sources said.
During a meeting of Parliamentary Standing Committee on Home Affairs, members also demanded that the maximum price of COVID-19 medicines be capped, they said.
Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting of the standing committee on home affairs chaired by Congress leader Anand Sharma.
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.
The committee members expressed concern over black marketing of medicines.
Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite they being equally effective.
also read
UK parliamentary committee publishes Boris Johnson's 'partygate' evidence
Parliament's Committee of Privileges, which has been looking into statements Johnson made to parliament in December 2021, said last week the former leader would also provide oral evidence to the committee in a televised session on March 22.
10 more people charged in $250M federal food program fraud
A total of 60 people have now been charged in the conspiracy, in which authorities say a group of people took advantage of rules that were relaxed during the COVID-19 pandemic and falsely claimed they were providing food to children.
This is why Beijing's population has declined for 1st time in 2 decades
Beijing's population decline was in line with national trends, with China's population falling last year for the first time in six decades